In numerous cancers, such as kidney, breast, and colon cancers, MUC1 also promotes cell migration and invasion by inducing epithelial-to-mesenchymal transition (EMT), a fundamental process by which polarized epithelial cells acquire mesenchymal cell properties with an enhanced motile and invasive capacity [17,31,32,33,34]. Here, MUC1 is linked to cancer.